TECH vs TLRY · P/E 65, rev $1.22B vs rev $821.3M
Bio-Techne Corp (TECH) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the TECH and TLRY stock pages for the full models.
Not investment advice.